用伊普塔科潘成功管理C3球膜病变的移植后复发:一个案例报告

Dario Troise1,2, Barbara Infante1, Silvia Mercuri1

  • 1Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.cK.A), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

概括

移植后的C3球囊病变 (C3G) 复发可能很难治疗. 补充剂抑制剂伊普塔科潘 (Iptacopan) 在移植患者中显示显著的临床和组织学改善,患者有C3G复发.